XML 25 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets and Goodwill
6 Months Ended
Jun. 30, 2020
Intangible Assets and Goodwill  
Intangible Assets and Goodwill

Note 4 – Intangible Assets and Goodwill

Intangible assets consist of the following at:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

$'s in 000's

​

​

​

​

​

Useful Lives

​

​

​

June 30, 2020

​

December 31, 2019

Amortizable intangibles

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Certification

​

​

​

​

​

7 years

​

​

​

$

350

​

$

350

Customer relationships

​

​

​

​

​

12-20 years

​

​

​

​

89,160

​

​

89,232

Patents and processes

​

​

​

​

​

5-10 years

​

​

​

​

4,810

​

​

4,928

Brand names

​

​

​

​

​

5-15 years

​

​

​

​

14,962

​

​

15,019

Total amortizable intangibles

​

​

​

​

​

​

​

​

​

​

109,282

​

​

109,529

Less accumulated amortization

​

​

​

​

​

​

​

​

​

​

(17,405)

​

​

(13,058)

Total net amortizable intangibles

​

​

​

​

​

​

​

​

​

​

91,877

​

​

96,471

Non-amortizable intangibles

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Trademarks and other

​

​

​

​

​

​

​

​

​

​

18,016

​

​

18,016

In-process research and development

​

​

​

​

​

​

​

​

​

​

5,469

​

​

5,469

Intangible assets, net of accumulated amortization

​

​

​

​

​

​

​

​

​

$

115,362

​

$

119,956

​

Certain intangible assets are denominated in currencies other than the U.S. Dollar; therefore, their gross and net carrying values are subject to foreign currency movements. Amortization expense for the three months ended June 30, 2020 and 2019 was $2.3 million and $1.3 million, respectively, and $4.5 million and $2.6 million for the six months ended June 30, 2020 and 2019, respectively.

The in-process research and development (“IPRD”), intangible assets represent the value assigned to acquired R&D projects that principally represent rights to develop and sell a product that the Company has acquired which have not yet been completed or approved. The IPRD acquired as part of the Perrigo Animal Health Acquisition is accounted for as an indefinite-lived asset until the product is available for sale and regulatory approval is obtained, or abandonment of the associated research and development efforts. If the research and development efforts are successfully completed, the IPRD would be amortized over its then estimated useful life. The fair value of the IPRD was estimated using the multi-period excess earnings income method. The projected cash flows estimates for the future products were based on certain key assumptions including estimates of future revenues and expenses, taking into account the stage of development at the acquisition date and the resources needed to complete development.

Estimated future amortization expense for each of the following years is as follows:

​

​

​

​

​

​

​

​

Years ending December 31, ($'s in 000's)

​

​

​

​

​

​

Remainder of 2020

​

​

​

​

$

4,479

2021

​

​

​

​

​

8,950

2022

​

​

​

​

​

9,151

2023

​

​

​

​

​

8,793

2024

​

​

​

​

​

6,787

Thereafter

​

​

​

​

​

53,717

​

The following is a summary of the changes in the carrying value of goodwill for the period from January 1, 2019 to June 30, 2020:

​

​

​

​

​

​

​

​

​

​

​

​

​

Reporting Unit

​

​

​

($'s in 000's)

​

Products

​

Services

​

Total

Goodwill as of January 1, 2019

​

​

77,765

​

​

47,264

​

​

125,029

Foreign currency translation

​

​

178

​

​

—

​

​

178

Acquisitions

​

​

105,838

​

​

—

​

​

105,838

Goodwill as of December 31, 2019

​

​

183,781

​

​

47,264

​

​

231,045

Foreign currency translation

​

​

(387)

​

​

—

​

​

(387)

Goodwill as of June 30, 2020

​

$

183,394

​

$

47,264

​

$

230,658

​